0.25 USD
▼0.00-8.35%
盘后 0.27 -1.83%
2026-08-03
市值
$990.74K
市盈率
—
EPS
-1.13
股息率
—
52 周区间
0.21 – 1.97
成交量
502.16K
Beta
2.11
目标价
—
52W 低 0.2152W 高 1.97
价格走势
公司简介
Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis. The company also offers contract development and manufacturing organization services, such as analytical metho...